View quarterly trends in buprenorphine dispensation data. Please note that buprenorphine data received by the PDMP is restricted to prescriptions filled by pharmacies. The PDMP does not collect information on the reason a controlled substance is prescribed, nor does it collect data from substance abuse treatment facilities or dispensing prescribers providing buprenorphine for substance abuse treatment. Buprenorphine is sometimes prescribed off-label for pain. Please see PDMP Data Technical Notes for additional details: https://www.health.pa.gov/topics/programs/PDMP/Pages/Data.aspx

This dataset is quarterly data by county, including inmate admissions, average Texas Christian University Drug Screen II (TCU) score, number and percent of inmate admissions who identify opioids as top three drug of choice, inmates with a substance abuse problem, and number and percent who used opioids in the year prior to admission.
This data is available starting with the first Quarter of Calendar Year 2016.

This dataset summarizes the number of dependent children (less than 18 years old) removed from households due to parental drug abuse. The data indicates if the dependent children were placed in kinship care or not.
The total number of children in this data set are provided by the U.S. Census Bureau’s American Community Survey (ACS), which publishes 5 year estimates of the population. The most recent year of entries in this data set may be available before the corresponding ACS population estimates for that year are published. In that case, the data set uses values from the most recently published ACS estimates and notes the year from which those estimates are pulled. These values are updated once the Census Bureau releases the most recent estimates.”
*Kinship care refers to the care of children by relatives or, in some jurisdictions, close family friends (often referred to as fictive kin). Relatives are the preferred resource for children who must be removed from their birth parents because it maintains the children's connections with their families.
*The Adoption and Foster Care Analysis and Reporting System (AFCARS) definition of parental drug abuse is “Principal caretaker’s compulsive use of drugs that is not of a temporary nature.”

Percent of Pennsylvania delivery hospital stays, categorized by the presence or absence of opioid use, that had reached specified gestation stages for the delivery stay.

Opioid use, or opioid use disorder, is a diagnosis indicating opioid dependence, abuse, or use. Some opioid drugs may be prescribed as part of medication-assisted treatment to relieve withdrawal symptoms and psychological cravings often associated with opioid use disorders. Opioid use during pregnancy can lead to Neonatal Abstinence Syndrome (NAS) for newborns.

Gestation stages specify the number of weeks of gestation at the time of the delivery stay. “Premature” indicates that the delivery stay is at 36 weeks or less of gestation, “Early Term” indicates that the delivery stay is at 37-38 weeks of gestation, and “Full Term or Longer” indicates that the delivery stay is at 39 weeks of gestation or longer.

This analysis is restricted to delivery hospital stays for Pennsylvania-state residents who were hospitalized in Pennsylvania hospitals.

Disclaimer:
PHC4’s database contains statewide hospital discharge data submitted to PHC4 by Pennsylvania hospitals. Every reasonable effort has been made to ensure the accuracy of the information obtained from the Uniform Claims and Billing Form (UB-82/92/04) data elements. Computer collection edits and validation edits provide opportunity to correct specific errors that may have occurred prior to, during or after submission of data. The ultimate responsibility for data accuracy lies with individual providers.

PHC4 agents and staff make no representation, guarantee, or warranty, expressed or implied that the data received from the hospitals are error-free, or that the use of this data will prevent differences of opinion or disputes with those who use published reports or purchased data. PHC4 will bear no responsibility or liability for the results or consequences of its use.

Countywide counts of maternal hospital stays with opioid use and countywide rates of maternal hospital stays with opioid use per 1,000 maternal stays.
Maternal stays include those involving a delivery, as well as other pregnancy-related stays. Opioid use, or opioid use disorder, is a diagnosis indicating opioid dependence, abuse, or use. Some opioid drugs may be prescribed as part of medication-assisted treatment to relieve withdrawal symptoms and psychological cravings often associated with opioid use disorders. Opioid use during pregnancy can lead to Neonatal Abstinence Syndrome (NAS) for newborns.
This analysis is restricted to maternal hospital stays for Pennsylvania-state residents who were hospitalized in Pennsylvania hospitals.
Disclaimer:
PHC4’s database contains statewide hospital discharge data submitted to PHC4 by Pennsylvania hospitals. Every reasonable effort has been made to ensure the accuracy of the information obtained from the Uniform Claims and Billing Form (UB-82/92/04) data elements. Computer collection edits and validation edits provide opportunity to correct specific errors that may have occurred prior to, during or after submission of data. The ultimate responsibility for data accuracy lies with individual providers.
PHC4 agents and staff make no representation, guarantee, or warranty, expressed or implied that the data received from the hospitals are error-free, or that the use of this data will prevent differences of opinion or disputes with those who use published reports or purchased data. PHC4 will bear no responsibility or liability for the results or consequences of its use.

Percent of Pennsylvania delivery hospital stays, categorized by the presence or absence of opioid use, that had at least one readmission within 365 of being discharged.

Opioid use, or opioid use disorder, is a diagnosis indicating opioid dependence, abuse, or use. Some opioid drugs may be prescribed as part of medication-assisted treatment to relieve withdrawal symptoms and psychological cravings often associated with opioid use disorders. Opioid use during pregnancy can lead to Neonatal Abstinence Syndrome (NAS) for newborns.

This analysis is restricted to delivery hospital stays with Pennsylvania-state residence who were hospitalized in Pennsylvania hospitals.

Disclaimer:
PHC4’s database contains statewide hospital discharge data submitted to PHC4 by Pennsylvania hospitals. Every reasonable effort has been made to ensure the accuracy of the information obtained from the Uniform Claims and Billing Form (UB-82/92/04) data elements. Computer collection edits and validation edits provide opportunity to correct specific errors that may have occurred prior to, during or after submission of data. The ultimate responsibility for data accuracy lies with individual providers.

PHC4 agents and staff make no representation, guarantee, or warranty, expressed or implied that the data received from the hospitals are error-free, or that the use of this data will prevent differences of opinion or disputes with those who use published reports or purchased data. PHC4 will bear no responsibility or liability for the results or consequences of its use.

This is a state aggregated filtered view from the original dataset describes as follows: quarterly data by county, including inmate admissions, average Texas Christian University Drug Screen II (TCU) score, number and percent of inmate admissions who identify opioids as top three drug of choice, inmates with a substance abuse problem, and number and percent who used opioids in the year prior to admission.
This data is available starting with the first Quarter of Calendar Year 2016.